mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.6 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |